HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
Clinical Data Presented at American Diabetes Association 82nd Scientific Sessions Reinforce Significant and Durable Benefits of Nevro’s HFX 10 kHz Therapy
The data presented at the ADA 82nd Scientific Sessions highlighted 24-month results for the original 10 kHz arm of the SENZA-PDN trial, the largest PDN RCT of SCS treatment conducted to date with 216 randomized subjects at 18 U.S. centers.
Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes
“Our Control-IQ technology continues to be a great equalizer for people with insulin-intensive diabetes, as we consistently see positive clinical and quality-of-life improvement with its use, regardless of age, ethnicity, or prior therapy,” said Jordan Pinsker, MD, Vice President and Medical Director for Tandem Diabetes Care.
Orbis Reports First-of-its-Kind Study Finds Artificial Intelligence Screenings Improve Eye Care Access in Sub-Saharan Africa
The study looked at whether the use of the Orbis Cybersight AI tool to detect diabetic retinopathy in images taken of the eye during routine screenings would lead to patients' increased uptake of diabetic retinopathy referral services.
Neuros Medical Announces Completion of QUEST Pivotal Trial 90-day Primary Endpoints
QUEST Pivotal Trial is a 180-subject randomized, double-blinded, active sham-controlled clinical trial that is being conducted under an Investigational Device Exemption
NYU Langone: Evidence Mounts for Alternate Origins of Alzheimer’s Disease Plaques
The field argued for decades that such plaques, containing the protein amyloid beta, built up outside of cells as a crucial first step toward the brain damage observed in Alzheimer’s disease.
New Study Reveals UltraSight & Sheba Medical Center Enable Novice Ultrasound Users to Obtain Accurate, Diagnostic Quality Cardiac Images
According to the results, UltraSight is effective at instructing novice medical professionals to acquire diagnostic quality exams in cardiac patients.
First Patients Enrolled in IMPACT II Study to Evaluate Attune Medical’s ensoETM for Radiofrequency Ablation Procedures
The data from thE IMPACT II Study will be used in pursuit of expanding the ensoETM’s intended use to include reduction of esophageal thermal injury during cardiac radiofrequency ablation procedures.
Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial
REBALANCE-HF study is evaluating a novel frontline therapy called Splanchnic Ablation for Volume Management (SAVM) that aims to rebalance volume distribution in heart failure patients with preserved ejection fraction.
Vectorious Announces VECTOR-HF I Study Confirms Safety and Accuracy of V-LAP In-Heart Sensor for Left Atrial Pressure Management of Heart Failure
The V-LAP system is implanted permanently in the left atrial wall of the heart to remotely calculate left atrial pressure (LAP).